Literature DB >> 20683243

Guidelines to implement medical examiner/coroner-based surveillance for fatal infectious diseases and bioterrorism ("Med-X").

Kurt B Nolte1, Marc Fischer, Sarah Reagan, Ruth Lynfield.   

Abstract

Medical examiners and coroners investigate deaths that are sudden, unexplained, and violent. Oftentimes these deaths are a consequence of infections, many of which have public health consequences. Additionally, because deaths from bioterrorism are homicides, they fall under the jurisdiction of medical examiners and coroners. Surveillance for infectious disease-related deaths can enhance the opportunities to recognize these deaths. Beginning in 2000, the New Mexico Office of the Medical Investigator developed and tested a medical examiner surveillance model for bioterrorism and infectious disease mortality ("Med-X") using a set of symptoms to determine which cases should receive an autopsy and a set of pathology-based syndromes for early reporting of cases to public health authorities. This model demonstrated that many of the symptoms had a high predictive value for infections and were useful criteria for autopsy performance. The causative organism was identified for 81% of infections of which 58% were notifiable conditions by public health standards. Uniform criteria for performing autopsies and reporting cases to public health authorities enhance surveillance for notifiable infectious diseases and increase the probability of recognizing fatalities related to bioterrorism. We have developed guidelines for medical examiners, coroners and their public health partners to use in implementing Med-X surveillance in their jurisdictions. These guidelines encompass definitions of symptoms and syndromes, specimen collection and storage procedures, laboratory diagnostic approaches, and processes for case flow, case reporting, and data collection. We also suggest resources for autopsy biosafety information and funding.

Entities:  

Mesh:

Year:  2010        PMID: 20683243     DOI: 10.1097/PAF.0b013e3181c187b5

Source DB:  PubMed          Journal:  Am J Forensic Med Pathol        ISSN: 0195-7910            Impact factor:   0.921


  7 in total

1.  How to optimise the yield of forensic and clinical post-mortem microbiology with an adequate sampling: a proposal for standardisation.

Authors:  A Fernández-Rodríguez; M C Cohen; J Lucena; W Van de Voorde; A Angelini; N Ziyade; V Saegeman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-14       Impact factor: 3.267

2.  How is post-mortem microbiology appraised by pathologists? Results from a practice survey conducted by ESGFOR.

Authors:  V Saegeman; M C Cohen; J Alberola; N Ziyade; C Farina; G Cornaglia; A Fernández-Rodríguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-24       Impact factor: 3.267

3.  Pandemic (H1N1) 2009-associated deaths detected by unexplained death and medical examiner surveillance.

Authors:  Christine H Lees; Catherine Avery; Ryan Asherin; Jean Rainbow; Richard Danila; Chad Smelser; Ann Schmitz; Stephen Ladd-Wilson; Kurt B Nolte; Kayla Nagle; Ruth Lynfield
Journal:  Emerg Infect Dis       Date:  2011-08       Impact factor: 6.883

4.  Fatal infectious diseases during pandemic (H1N1) 2009 outbreak.

Authors:  Dianna M Blau; Amy M Denison; Julu Bhatnagar; Marlene DeLeon-Carnes; Clifton Drew; Christopher Paddock; Wun-Ju Shieh; Sherif R Zaki
Journal:  Emerg Infect Dis       Date:  2011-11       Impact factor: 6.883

5.  Determinants for autopsy after unexplained deaths possibly resulting from infectious causes, United States.

Authors:  Lindy Liu; Laura L Sinden; Robert C Holman; Dianna M Blau
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

6.  Infectious disease surveillance by medical examiners and coroners.

Authors:  Dianna M Blau; Steven C Clark; Kurt B Nolte
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

7.  CDC Grand Rounds: discovering new diseases via enhanced partnership between public health and pathology experts.

Authors:  Sherif Zaki; Dianna M Blau; James M Hughes; Kurt B Nolte; Ruth Lynfield; Wendy Carr; Tanja Popovic
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-02-14       Impact factor: 17.586

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.